NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
1.960
+0.060 (3.16%)
At close: Aug 14, 2026, 4:00 PM EDT
1.970
+0.010 (0.49%)
After-hours: Aug 14, 2026, 7:55 PM EDT

NovaBridge Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
210.6368.26291.51465.99554.68
Short-Term Investments
0.21105.1420.2234.8118.56
Cash & Short-Term Investments
210.84173.4311.73500.78673.24
Cash Growth
21.59%-44.38%-37.75%-25.61%-8.25%
Accounts Receivable
----45.16
Other Receivables
1.791.171.834.8116
Receivables
1.791.171.834.8161.16
Inventory
----4.29
Prepaid Expenses
0.71.130.121.381.41
Restricted Cash
---14.03-
Other Current Assets
4.19116.234.7812.62
Total Current Assets
217.52176.69329.91525.79752.72
Property, Plant & Equipment
2.953.85.5517.9724.95
Long-Term Investments
37.2430.82-4.4755.43
Goodwill
---23.5725.59
Other Intangible Assets
---17.2418.84
Other Long-Term Assets
2.811.3733.461.584.19
Total Assets
260.52212.68368.92590.63881.72

Liabilities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accrued Expenses
16.827.536.58100.4892.27
Short-Term Debt
---2.75-
Current Portion of Leases
0.890.820.633.474.83
Current Unearned Revenue
---1.26-
Other Current Liabilities
9.180.1150.941.961.13
Total Current Liabilities
26.898.4558.14109.9298.23
Long-Term Leases
2.183.073.264.6512.87
Long-Term Unearned Revenue
---38.8435.26
Other Long-Term Liabilities
0.51-64.9315.3217.61
Total Liabilities
29.5811.52126.34168.73163.97

Shareholders' Equity

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.030.020.020.020.02
Additional Paid-In Capital
1,5271,4601,4751,3891,433
Retained Earnings
-1,332-1,286-1,264-994.92-685.52
Treasury Stock
-5.04-6.23-8.01-3.08-
Comprehensive Income & Other
41.5533.3839.7731-29.36
Total Common Equity
230.94201.16242.58421.9717.75
Shareholders' Equity
230.94201.16242.58421.9717.75
Total Liabilities & Equity
260.52212.68368.92590.63881.72

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
3.073.883.8910.8717.7
Net Cash (Debt)
207.78169.52307.84489.91655.53
Net Cash Growth
22.57%-44.93%-37.16%-25.26%-10.41%
Net Cash Per Share
2.172.093.705.948.63
Filing Date Shares Outstanding
115.6581.580.782.9982.55
Total Common Shares Outstanding
115.3881.580.782.9979.92
Working Capital
190.63168.24271.77415.87654.49
Book Value Per Share
2.002.473.015.088.98
Tangible Book Value
230.94201.16242.58381.09673.32
Tangible Book Value Per Share
2.002.473.014.598.42
Machinery
--1.779.336.1
Construction In Progress
---0.93.32
Leasehold Improvements
--0.875.422.98
SEC Filings: 10-K · 10-Q